Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Yael L. Maxwell

December 12, 2022

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Shelley Wood

December 01, 2022

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

L.A. McKeown

November 21, 2022

News Conference News AHA 2022

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

Michael O'Riordan

November 10, 2022

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News TCT 2022

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Yael L. Maxwell

September 26, 2022

News Conference News TCT 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Yael L. Maxwell

September 23, 2022

Presentation TCT 2022

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

Presenter: Bahira Shahim

September 18, 2022

Presentation TCT 2022

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

Presenter: edoardo zancanaro

September 18, 2022

Presentation TCT 2022

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Andrea Scotti

September 18, 2022

Presentation TCT 2022

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Chandrashekar Bohra

September 18, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

Advertisement

December 2022 News Roundup

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Pascal TEER Device Performs Well in Patients With Complex Anatomy

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

TCT 338: Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

TCT 337: Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

TCT 336: Eligibility to Coapt Trial in the Daily Practice: a Real-World Experience

TCT 335: Mitral Regurgitation Severity to Left Atrial Volume Ratio in Heart Failure Patients with Secondary Mitral Regurgitation: The COAPT Trial

TCT 334: Pulmonary Venous Flow Pattern as a Predictor of Outcomes in Patients With Secondary Mitral Regurgitation: The COAPT Trial

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

FDA Approves Pascal TEER Device for Degenerative MR

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content